77036 Federal Register / Vol. 71, No. 246 / Friday, December 22, 2006 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Cellular 

and Tissue Biology Cluster. 

Date: January 30–31, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott, 5701 

Marinelli Road, Bethesda, MD 20852. 

Contact Person: Shakeel Ahmad, PhD, 

Scientific Review Administrator, Research 

Programs Review Branch, National Cancer 

Institute, Division of Extramural Activities, 

6116 Executive Blvd., Room 8137, MSC 8328, 

Bethesda, MD 20892, (301) 594–0114, 

ahmads@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel Prevention, 

Control and Population Sciences. 

Date: February 7–9, 2007. 

Time: 5 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Hasnaa Shafik, MD, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, RPRB, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8135, Bethesda, MD 

20892, (301) 451–4757, 

shafikh@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Cancer 

Prevention, Control and Population Sciences. 

Date: February 7–9, 2007. 

Time: 5 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Wlodek Lopaczynski, MD, 

PhD, Scientific Review Administrator, 

Research Programs Review Branch, Division 

of Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8131, 

Bethesda, MD 20892, 301–594–1402, 

lopacw@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support, 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 14, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9816 Filed 12–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings 

The meetings will be closed to the 

public in accordance with the 

provisions seth forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C, 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Unsolicited Program Project 

(P01) Grant Application. 

Date: January 10, 2007. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817, (Telephone Conference 

Call). 

Contact Person: Kenneth E. Santora, PhD, 

Scientific Review Administrator, Scientific 

Review Program, NIH/NIAID/DHHS, Room 

3265, 6700B Rockledge Drive, MSC 7616, 

Bethesda, MD 20892, (301) 451–2605, 

ks216i@nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Clinical Trials Planning 

Grants. 

Date: January 16, 2007. 

Time: 10 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817, (Telephone Conference 

Call). 

Contact Person: Barney Duane Price, PhD, 

Scientific Review Administrator, Scientific 

Review Program, DHSS/NIH/NIAID/DEA, 

Room 2217, 6700B Rockledge Drive, MSC 

7616, Bethesda, MD 20892–7616, 301–496–

2550, pricebd@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Non-Antibiotic Selectable 

Markers for Biodefense. 

Date: January 17, 2007. 

Time: 8 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: North Bethesda Marriott, 5701 

Marinelli Road, North Bethesda, MD 20852. 

Contact Person: Mary J. Homer, PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, NIAID/NIH/DHHS, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892, (301) 496–7042, 

mjhomer@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, New Drug Discovery for 

Tuberculosis. 

Date: January 26, 2007. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817, (Telephone Conference 

Call). 

Contact Person: Darren D Sledjeski, PhD, 

Scientific Review Administrator, NIAID, 

DEA, Scientific Review Program, Room 3253, 

6700B Rockledge Drive, MSC–7616, 

Bethesda, MD 20892–7616, 301– 451–2638, 

sledjeskid@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 15, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9817 Filed 12–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 71, No. 246 / Friday, December 22, 2006 / Notices 77037 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SAT Study 

Section Conflicts. 

Date: January 23, 2007. 

Time: 1 p.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Dharam S. Dhindsa, DVM, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5110, 

MSC 7854, Bethesda, MD 20892, (301) 435–

1174, dhindsad@csr.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group, Neurobiology of 

Learning and Memory Study Section. 

Date: February 1, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, NW., Washington, DC 

20037. 

Contact Person: Bernard F. Driscoll, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5184, 

MSC 7844, Bethesda, MD 20892, (301) 435–

1242, driscolb@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group, Biobehavioral Regulation, Learning 

and Ethology Study Section. 

Date: February 1–2, 2007. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street 

NW., Washington, DC 20036. 

Contact Person: Luci Roberts, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3188, 

MSC 7848, Bethesda, MD 20892, (301) 435–

0692, roberlu@csr.nih.gov. 

Name of Committee: Digestive Sciences 

Integrated Review Group, Clinical and 

Integrative Gastrointestinal Pathobiology 

Study Section. 

Date: February 4–5, 2007. 

Time: 7 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Mushtaq A. Khan, DVM, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2176, 

MSC 7818, Bethesda, MD 20892, (301) 435–

1778, khanm@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group, Macromolecular Structure 

and Function A Study Seciton. 

Date: February 5–6, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: Janet Nelson, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4168, 

MSC 7806, Bethesda, MD 20892, (301) 435–

1723, nelsonja@csr.nih.gov. 

Name of Committee: Digestive Sciences 

Integrated Review Group, Gastrointestinal 

Cell and Molecular Biology Study Section. 

Date: February 5–6, 2007. 

Time: 1 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Najma Begum, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2175, 

MSC 7818, Bethesda, MD 20892, (301) 435–

1243, begumn@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflicts: Memory. 

Date: February 5, 2007. 

Time: 1 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Edwin C. Clayton, PhD, 

Scientific Review Administrator Intern, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 5095C, MSC 7844, Bethesda, MD 

20892, (301) 402–1304, claytone@csr.nih.gov. 

Name of Committee: Digestive Sciences 

Integrated Review Group, Xenobiotic and 

Nutrient Disposition and Action Study 

Section. 

Date: February 7–8, 2007. 

Time: 8 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Patricia Greenwel, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2174, 

MSC 7818, Bethesda, MD 20892, 301–435–

1169, greenwep@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, Clinical 

and Integrative Diabetes and Obesity Study 

Section. 

Date: February 8–9, 2007. 

Time: 8 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crystal City Marriott, 1999 Jefferson 

Davis Highway, Arlington, VA 22202. 

Contact Person: Nancy Sheard, SCD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6046–E, 

MSC 7892, Bethesda, MD 20892, 301–435–

1154, sheardn@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group, Macromolecular Structure 

and Function B Study Section. 

Date: February 8–9, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: Nancy Lamontagne, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4168, 

MSC 7806, Bethesda, MD 20892, (301) 435–

1726, lamontan@csr.nih.gov. 

Name of Committee: Hematology 

Integrated Review Group, Hematopoiesis 

Study Section. 

Date: February 8–9, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Robert T. Su, PhD., 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4134, 

MSC 7802, Bethesda, MD 20892, (301) 435–

1195, sur@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group, 

Pathogenic Eukaryotes Study Section. 

Date: February 8–9, 2007. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Jean Hickman, PhD., 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3194, 

MSC 7808, Bethesda, MD 20892, (301) 435–

1146, hickmanj@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group, Neurodifferentiation, 

Plasticity, and Regeneration Study Section. 

Date: February 13–14, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Jury’s Hotel, 1500 New Hampshire 

Avenue, NW., Washington, DC 20032. 

Contact Person: Joanne T. Fujii, PhD., 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5204, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1178, fujiij@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Health of 

the Population Fellowship Review Special 

Emphasis Panel. 

Date: February 15, 2007. 


jlentini on PROD1PC65 with NOTICES
77038 Federal Register / Vol. 71, No. 246 / Friday, December 22, 2006 / Notices 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Fungai F. Chanetsa, PhD., 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3135, 

MSC 7770, Bethesda, MD 20892, 301–435–

1262, chanetsaf@csr.nih.gov. 

Name of Committee: Health of the 

Population Integrated Review Group, 

Cardiovascular and Sleep Epidemiology 

Study Section. 

Date: February 15–16, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Park Hotel, 8400 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: J. Scott Osborne, PhD., 

MPH, Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 4114, MSC 7816, Bethesda, MD 20892, 

(301) 435–1782, osbornes@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group, 

Psychosocial Development, Risk and 

Prevention Study Section. 

Date: February 15–16, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Victoria S. Levin, MSW, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3142, 

MSC 7759, Bethesda, MD 20892, (301) 435–

0912, levinv@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group, Neurotransporters, Receptors, 

and Calcium Signaling Study Section. 

Date: February 15–16, 2007. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Peter B. Guthrie, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4182, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1239, guthriep@csr.nih.gov. 

Name of Committee: Cardiovascular 

Sciences Integrated Review Group, Electrical 

Signaling, Ion Transport, and Arrhythmias 

Study Section. 

Date: February 15–16, 2007. 

Time: 8:30 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Rajiv Kumar, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4122, 

MSC 7802, Bethesda, MD 20892, (301) 435–

1212, kumarra@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special emphasis Panel, 

Bioengineering Research Partnership. 

Date: February 16, 2007. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Hotel, 998 West Mission Bay 

Drive, San Diego, CA 92109. 

Contact Person: Behrouz Shabestari, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5106, 

MSC 7854, Bethesda, MD 20892, (301) 435–

2409, shabestb@csr.nih.gov. 

Name of Committee: Health of the 

Population Integrated Review Group, 

Biostatistical Methods and Research Design 

Study Section. 

Date: February 16, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: George Washington University Inn, 

824 New Hampshire Ave., NW., Washington, 

DC 20037. 

Contact Person: Ann Hardy, DRPH, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3158, 

MSC 7770, Bethesda, MD 20892, (301) 435–

0695, hardyan@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Community 

Level Health Promotion R21, R15, and R03’s. 

Date: February 16, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Fungai F. Chanestsa, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3135, 

MSC 7770, Bethesda, MD 20892, (301) 435–

1262, chanetsaf@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 14, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9797 Filed 12–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Method of Treating or 

Preventing Cancer Using 

Radiosensitizing Agents 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

Part 404.7(a)(1)(i), that the National 

Institutes of Health, Department of 

Health and Human Services, is 

contemplating the grant of an exclusive 

patent license to practice the invention 

embodied in U.S. Provisional Patent 

Application No. 60/718,172, filed 

September 16, 2005, entitled ‘‘Method 

of Treating or Preventing Cancer Using 

Pyridine Carboxaldehyde Pyridine 

Thiosemicarbazone Radiosensitizing 

Agents’’ [E–319–2005/0–US–01; E–319–

2005/0–PCT–02], to Vion 

Pharmaceuticals, Inc., having a place of 

business in New Haven, Connecticut. 

The patent rights in these inventions 

have been assigned to the United States 

of America. 

The prospective exclusive license 

territory may be worldwide, and the 

field of use may be limited to the use 

of the Triapine as a radiosensitizer as 

claimed in the licensed patent rights for 

the treatment of cancer and other 

tumors. 

DATES: Only written comments and/or 

applications for a license which are 

received by the NIH Office of 

Technology Transfer on or before 

February 20, 2007 will be considered. 

ADDRESSES: Requests for copies of the 

patent application, inquiries, comments, 

and other materials relating to the 

contemplated exclusive license should 

be directed to: Adaku Madu, J.D., 

Technology Licensing Specialist, Office 

of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, MD 

20852–3804; Telephone: (301) 435–

5560; Facsimile: (301) 402–0220; E-mail: 

madua@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: This 

technology relates to using 2- 

carboxyaldehyde pyridine 

thiosemicarbazone compounds or 

prodrugs thereof, specifically 3-amino2-carboxyaldehyde pyridine 

thiosemicarbazone (Triapine) or 4- 

methyl-3-amino-2-carbozyaldehyde 

pyridine thiosemicarbazone, as 

radiosensitizing agents prior to 

administering ionizing radiation. 


jlentini on PROD1PC65 with NOTICES